SynopsisThe global NASH Therapeutic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing.....
SynopsisThe global Non-Alcoholic Steatohepatitis (NASH) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 bill.....
SynopsisThe global PD-1 and PD-L1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for PD-1 and PD-L1 Antibody is estimated to in.....
SynopsisThe global PD-1 and PD-L1 Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for PD-1 and PD-L1 Immunotherapy is estim.....
SynopsisThe global GLP-1R Agonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for GLP-1R Agonist is estimated to increase from $ mill.....
SynopsisThe global Glucagon-like Peptide-1 Receptor Agonist market was valued at US$ 8816.2 million in 2023 and is anticipated to reach US$ 21040 million by 2030, witnessing a CAGR of 13.0% during the forecast period 2024-2030. According to our research, the glo.....
SynopsisThe global GLP-1 Receptor Agonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for GLP-1 Receptor Agonists is estimated to in.....
SynopsisThe global Incretin Mimetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices is estima.....
SynopsisThe global H2 Antagonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for H2 Antagonist is estimated to increase from $ millio.....
SynopsisThe global Enzyme Poly ADP Ribose Polymerase Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Enzyme Poly ADP Ribose.....
